Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 11, 2023
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature reviewWilliam J Archibald, Peter A Kouides, Majed A Refaai, et al.Journal of Geriatric Oncology|July 16, 2019
Immune checkpoint inhibitors in older adults with melanoma or cutaneous malignancies: The Wilmot Cancer Institute experienceWilliam J Archibald, Adrienne I Victor, Myla S Strawderman, et al.Animal Welfare (South Mimms, England)|March 15, 2024
Development of a novel primate welfare assessment tool for research macaquesEmilie A Paterson, Carly I O'Malley, Dawn M Abney, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2020
Brief Communication: Immune Checkpoint Inhibitor-induced Diaphragmatic Dysfunction: A Case SeriesWilliam J Archibald, Dagny K Anderson, Thomas J Breen, et al.Leukemia Research|July 14, 2018
Management of melanoma in patients with chronic lymphocytic leukemiaWilliam J Archibald, Philip J Meacham, AnnaLynn M Williams, et al.Leukemia Research|March 12, 2023
The role of splenectomy in management of splenic B-cell lymphomasWilliam J Archibald, Andrea M Baran, AnnaLynn M Williams, et al.Artificial Organs|June 8, 2017
Cannulation-Related Complications on Veno-Arterial Extracorporeal Membrane Oxygenation: Prevalence and Effect on MortalityJoshua K Wong, Amber L Melvin, Devang J Joshi, et al.Leukemia & Lymphoma|March 17, 2020
Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)Philip J Meacham, AnnaLynn M Williams, Myla Strawderman, et al.The Journal of Thoracic and Cardiovascular Surgery|June 6, 2017
Early and late outcomes with prolonged open chest management after cardiac surgeryJoshua K Wong, Devang J Joshi, Amber L Melvin, et al.Annals of Hematology|June 4, 2020
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomesWilliam J Archibald, Kari G Rabe, Brian F Kabat, et al.Pageof 2